Yale University

The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.

TitleThe impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.
Publication TypeJournal Article
Year of Publication2014
AuthorsEdelman, Jennifer E., Tongtan Chantarat, Sarah Caffrey, Amina Chaudhry, Patrick G. O'Connor, Linda Weiss, David A. Fiellin, and Lynn E. Fiellin
JournalDrug and alcohol dependence
Date Published2014 Mar 15
ISSN1879-0046
AbstractOpioid dependence is a major risk factor for HIV infection, however, the impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected opioid-dependent patients is unknown.
DOI10.1016/j.drugalcdep.2014.03.006
Alternate JournalDrug Alcohol Depend

External Links